UBS Group
AGN

UBS Group’s Allergan plc AGN Stock Holding History

UBS Group’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-175,000
Closed -$29.5M – 8649
2019
Q3 		$29.5M Buy
175,000
+147,450
+535% +$24M 0.01% 993
2019
Q2 		$4.61M Sell
27,550
-47,700
-63% -$6.6M ﹤0.01% 2394
2019
Q1 		$11M Buy
75,250
+73,375
+3,913% +$10.6M ﹤0.01% 1605
2018
Q4 		$251K Sell
1,875
-4,501
-71% -$738K ﹤0.01% 4785
2018
Q3 		$1.22M Buy
+6,376
New +$1.17M ﹤0.01% 3664
2018
Q1 		– Sell
-62,500
Closed -$10.2M – 8367
2017
Q4 		$10.2M Sell
62,500
-17,100
-21% -$3.07M ﹤0.01% 1696
2017
Q3 		$16.3M Buy
79,600
+21,900
+38% +$5.09M 0.01% 1242
2017
Q2 		$14M Sell
57,700
-43,404
-43% -$10.2M 0.01% 1280
2017
Q1 		$24.2M Sell
101,104
-85,996
-46% -$20M 0.01% 915
2016
Q4 		$39.3M Sell
187,100
-175,400
-48% -$36.3M 0.02% 655
2016
Q3 		$83.5M Sell
362,500
-203,600
-36% -$49.8M 0.05% 368
2016
Q2 		$131M Buy
566,100
+91,900
+19% +$21.2M 0.08% 250
2016
Q1 		$127M Sell
474,200
-120,900
-20% -$34.6M 0.09% 236
2015
Q4 		$186M Buy
595,100
+556,400
+1,438% +$166M 0.12% 190
2015
Q3 		$10.5M Buy
38,700
+35,500
+1,109% +$10.9M 0.01% 1327
2015
Q2 		$971K Sell
3,200
-3,100
-49% -$925K ﹤0.01% 3594
2015
Q1 		$1.88M Sell
6,300
-7,800
-55% -$2.22M ﹤0.01% 2992
2014
Q4 		$3.63M Buy
+14,100
New +$3.52M ﹤0.01% 2362

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

UBS Group's AGN Position: Q2 2020 in Review

UBS Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 6,853,356 shares — an estimated $1.21B sold.

UBS Group first reported a position in AGN in Q4 2014 and held it in 22 quarters. The position peaked at $1.23B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • UBS Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • UBS Group sold 6,853,356 Allergan plc shares in Q2 2020, an estimated $1.21B.
  • UBS Group first reported a position in Allergan plc in Q4 2014 and held it in 22 quarters.
  • UBS Group's Allergan plc position peaked at $1.23B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on UBS Group's 13F filing for Q2 2020, filed 31 Jul 2020.